SCHEMBL3683016

SCHEMBL3683016

CC=C(C)C(=O)OC1COC(C)(C)O1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.33
CA2 P00918 2/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 2/20 0.33
CYP3A4 P08684 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDR P35968 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 2/20 0.30
KMT2A Q03164 2/20 0.30
RCE1 Q9Y256 1/20 0.30
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
MEN1 O00255 1/20 0.30
RECQL P46063 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
ABCB1 P08183 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5699106 1.00 MAPT (0.33) MAPTCA2KDM4EHPGDCYP3A4
SCHEMBL20835342 0.82 KDR (0.33) MAPTKDM4EHPGDCYP3A4HSD17B10
SCHEMBL10716770 0.81 ALDH1A1 (0.41) CA2L3MBTL1ALDH1A1
SCHEMBL27404455 0.80 TSHR (0.41) CA2L3MBTL1ALDH1A1NPSR1
SCHEMBL28912789 0.80 CA2 (0.37) CA2L3MBTL1NPSR1
SCHEMBL27427939 0.80 TSHR (0.41) CA2L3MBTL1ALDH1A1NPSR1
SCHEMBL15151257 0.80 TSHR (0.41) CA2L3MBTL1ALDH1A1NPSR1
SCHEMBL29086833 0.79 L3MBTL1 (0.33) CA2L3MBTL1
SCHEMBL5597174 0.79 L3MBTL1 (0.36) CA2L3MBTL1
SCHEMBL28635110 0.78 ALDH1A1 (0.34) MAPTKDM4EHPGDCYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110139903-B Antifouling coating composition comprising novel carbon-based hydrolysable polymers 汉伯公司 2022-01-28 CN claimed
US-7645846-B2 Useful as monomer for the preparation of hemocompatible coating, medical device, water soluble polymer material, paint, water borne coating, or an ocular device (contact lenses) COOPERVISION INTERNATIONAL HOLDING COMPANY LP (BB) 2010-01-12 US claimed
CN-110139903-B Antifouling coating composition comprising novel carbon-based hydrolysable polymers 汉伯公司 2022-01-28 CN disclosed
CN-112368631-A Ophthalmic lens with photochromic coating and method for producing same 卡尔蔡司光学国际有限公司 2021-02-12 CN disclosed
CN-109997069-B Spectacle lens and method for producing the same 卡尔蔡司光学国际有限公司 2021-02-09 CN disclosed
US-20160054300-A1 REFERENCE STANDARD FOR DIAGNOSTIC APPLICATIONS WINTHER LARS (DK) 2016-02-25 US disclosed
US-7645846-B2 Useful as monomer for the preparation of hemocompatible coating, medical device, water soluble polymer material, paint, water borne coating, or an ocular device (contact lenses) COOPERVISION INTERNATIONAL HOLDING COMPANY LP (BB) 2010-01-12 US disclosed
EP-1694494-A4 CONTACT LENSES AND PROCESSES FOR MANUFACTURING CONTACT LENSES MENICON CO LTD (JP) 2009-08-26 EP disclosed
EP-1642131-B1 STANDARD DAKO DENMARK AS (DK) 2008-10-29 EP disclosed
EP-1597578-B1 STANDARD FOR IMMUNOHISTOCHEMISTRY, IMMUNOCYTOCHEMISTRY AND MOLECULAR CYTOGENETICS. DAKO DENMARK AS (DK) 2006-12-20 EP disclosed
EP-1694494-A2 CONTACT LENSES AND PROCESSES FOR MANUFACTURING CONTACT LENSES 1-800 Contacts Inc. (US) 2006-08-30 EP disclosed
US-6610895-B2 Useful as monomer for the preparation of hemocompatible coating, medical device, water soluble polymer material, paint, water borne coating, or ocular device (contact lenses) HYDRON LIMITED (GB) 2003-08-26 US disclosed
US-20020042546-A1 Process for the preparation of a diol COOPERVISION INTERNATIONAL LIMITED (GB) 2002-04-11 US disclosed
US-20020042549-A1 Process for the preparation of a diol COOPERVISION INTERNATIONAL LIMITED (GB) 2002-04-11 US disclosed
EP-1171410-A1 PROCESS FOR THE PREPARATION OF A DIOL Hydron Limited (GB) 2002-01-16 EP disclosed
WO-2001004234-A1 METHOD OF STABILISING AN INVERSE LYOTROPIC LIQUID CRYSTALLINE PHASE IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (GB) 2001-01-18 WO disclosed
WO-2000063149-A1 PROCESS FOR THE PREPARATION OF A DIOL HYDRON LIMITED (GB) 2000-10-26 WO disclosed
EP-0243120-B1 TOUGH FLEXIBLE POLYMER BLENDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-01-20 EP disclosed
US-5053276-A Computer storage disks, optical fibers ROHM GMBH CHEMISCHE FABRIK (DE) 1991-10-01 US disclosed
US-4985504-A STYRENE POLYMER, HETEROCYCLIC ACRYLATE POLYMER ROHM GMBH CHEMISCHE FABRIK (DE) 1991-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042546-A1 Process for the preparation of a diol SI, SORD, ADH1C MAPT 3991/4885CA2 1229/4885KDM4E 3767/4885
US-20020042549-A1 Process for the preparation of a diol INHA, F12, F13A1 MAPT 3041/4885CA2 813/4885KDM4E 3770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.